| Citation: |
CHEN Hui, ZHANG Li, LU Chen, CAI Xindi. Establishment and validation of a Nomogram predictionmodel for risk of multi-drug resistant infection after operation of cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 45-49, 54. DOI: 10.7619/jcmp.20234252
|
To investigate the risk factors for postoperative multi-drug resistant infection in patients with cerebral hemorrhage and establish a Nomogram prediction model.
Clinical materials of 241 patients with surgery for cerebral hemorrhage in the hospital from July 2020 to July 2023 were collected, and they were divided into infection group and non-infection group. Logistic regression models were used to analyze independent influencing factors for the occurrence of postoperative multi-drug resistant infection in patients with cerebral hemorrhage, and a Nomogram prediction model was constructed accordingly. The predictive performance of the Nomogram was evaluated by the consistency index (C-index), the receiver operating characteristic (ROC) curve, and the calibration curve.
A total of 241 patients with cerebral hemorrhage were included in this study, among which 56 cases (24.24%) had postoperative multi-drug resistant infection. In the infection group, the preoperative Glasgow Coma Scale (GCS) score, ratio of preoperative vomiting, ratio of preoperative antibiotic treatment, ratio of gastric tube indwelling, ratio of tracheotomy, and ratio of intubation were significantly higher than those in the non-infection group (P < 0.05). Logistic regression analysis revealed that preoperative GCS score ≤8, preoperative vomiting, preoperative antibiotic treatment, gastric tube indwelling, tracheotomy and intubation were the independent risk factors for postoperative multi-drug resistant infection in patients with cerebral hemorrhage (OR > 1, P < 0.05). Values of area under thecurve (AUC) for preoperative GCS score, preoperative vomiting, preoperative antibiotic treatment, tracheotomy and intubation were all above 0.700, indicating these indicators have good predictive value for the occurrence of postoperative multi-drug resistant infection in such patients. Based on these influencing factors, a Nomogram risk model was established. The C-index value of the calibration curve was 0.798, suggesting the Nomogram model has good discriminatory power. The AUC values for the modeling group and validation group in the ROC curve were 0.798 and 0.722 respectively, indicating that the Nomogram model possesses satisfactory predictive efficacy.
Nomogram prediction model constructed based on independent risk factors for postoperative multi-drug resistant infection in patients with cerebral hemorrhage can effectively predict the probability of such infections occurring in these patients after surgery.
| [1] |
O'CARROLL C B, BROWN B L, FREEMAN W D. Intracerebral hemorrhage: a common yet disproportionately deadly stroke subtype[J]. Mayo Clin Proc, 2021, 96(6): 1639-1654. doi: 10.1016/j.mayocp.2020.10.034
|
| [2] |
IRONSIDE N, CHEN C J, DING D L, et al. Perihematomal edema after spontaneous intracerebral hemorrhage[J]. Stroke, 2019, 50(6): 1626-1633. doi: 10.1161/STROKEAHA.119.024965
|
| [3] |
SCHRAG M, KIRSHNER H. Management of intracerebral hemorrhage: JACC focus seminar[J]. Am Coll Cardiol, 2020, 75(15): 1819-1831. doi: 10.1016/j.jacc.2019.10.066
|
| [4] |
D'AMATO S A, CHANG T R. Advances in intracranial hemorrhage: subarachnoid hemorrhage and intracerebral hemorrhage[J]. Crit Care Clin, 2023, 39(1): 71-85. doi: 10.1016/j.ccc.2022.06.003
|
| [5] |
周媛媛, 周珏, 许飚, 等. 某中医院重症监护病房医院感染现状及患者预后分析[J]. 实用临床医药杂志, 2023, 27(10): 117-123. doi: 10.7619/jcmp.20223883
|
| [6] |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2014)[J]. 中华神经科杂志, 2015, 48(6): 435-444. doi: 10.3760/cma.j.issn.1006-7876.2015.06.002
|
| [7] |
DIKMEN S, MACHAMER J, MANLEY G T, et al. Functional status examination versus Glasgow outcome scale extended as outcome measures in traumatic brain injuries: how do they compare[J]. Neurotrauma, 2019, 36(16): 2423-2429. doi: 10.1089/neu.2018.6198
|
| [8] |
HOSTETTLER I C, SEIFFGE D J, WERRING D J. Intracerebral hemorrhage: an update on diagnosis and treatment[J]. Expert Rev Neurother, 2019, 19(7): 679-694. doi: 10.1080/14737175.2019.1623671
|
| [9] |
KASE C S, HANLEY D F. Intracerebral hemorrhage: advances in emergency care[J]. Neurol Clin, 2021, 39(2): 405-418. doi: 10.1016/j.ncl.2021.02.002
|
| [10] |
DE OLIVEIRA MANOEL A L. Surgery for spontaneous intracerebral hemorrhage[J]. Crit Care, 2020, 24(1): 45. doi: 10.1186/s13054-020-2749-2
|
| [11] |
BUKOWSKI K, KCIUK M, KONTEK R. Mechanisms of multidrug resistance in cancer chemotherapy[J]. Int Mol Sci, 2020, 21(9): 3233. doi: 10.3390/ijms21093233
|
| [12] |
王丹, 朱丹, 邹妮. 多重耐药菌医院感染的经济负担研究进展[J]. 老年医学与保健, 2021, 27(2): 417-419. doi: 10.3969/j.issn.1008-8296.2021.02.052
|
| [13] |
MOISEEVA N I, LALETINA L A, FETISOV T I, et al. Analysis of multiple drug resistance mechanism in different types of soft tissue sarcomas: assessment of the expression of ABC-transporters, MVP, YB-1, and analysis of their correlation with chemosensitivity of cancer cells[J]. Int Mol Sci, 2022, 23(6): 3183. doi: 10.3390/ijms23063183
|
| [14] |
CHEN S P, LI L Z, PENG C, et al. Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage[J]. Antioxid Redox Signal, 2022, 37(1/2/3): 115-134.
|
| [15] |
RHIM H Y, WON S Y, KASHEFIOLASL S, et al. Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)[J]. Sci Rep, 2021, 11(1): 8309. doi: 10.1038/s41598-021-87863-y
|
| [16] |
MAGID-BERNSTEIN J, GIRARD R, POLSTER S, et al. Cerebral hemorrhage: pathophysiology, treatment, and future directions[J]. Circ Res, 2022, 130(8): 1204-1229. doi: 10.1161/CIRCRESAHA.121.319949
|
| [17] |
DING W L, XIANG Y S, LIAO C, et al. Early tracheostomy is associated with better prognosis in patients with brainstem hemorrhage[J]. Integr Neurosci, 2020, 19(3): 437-442. doi: 10.31083/j.jin.2020.03.25
|
| [18] |
LUO B, CHEN H X, SONG X D, et al. Timing of tracheostomy in patients with intracerebral haemorrhage: a propensity-matched analysis[J]. Curr Neurovasc Res, 2022, 19(3): 367-377. doi: 10.2174/1567202619666220920122935
|
| [19] |
YANG H J, FAN Y S, LI C H, et al. A retrospective study on risk factors and disease burden for hospital-acquired pneumonia caused by multi-drug-resistant bacteria in patients with intracranial cerebral hemorrhage[J]. Neurol Sci, 2022, 43(4): 2461-2467. doi: 10.1007/s10072-021-05721-1
|
| [20] |
刘超, 杨昱琦, 耿文, 等. 定期变换气管插管套囊位置对减少气道黏膜损伤的应用研究[J]. 护士进修杂志, 2020, 35(9): 853-855. https://www.cnki.com.cn/Article/CJFDTOTAL-FSJX202009027.htm
|
| [21] |
YIN B, LI W H, YU H, et al. Study of adverse events of endotracheal intubation[J]. Zhongguo Yi Liao Qi Xie Za Zhi, 2021, 45(6): 692-697.
|
| 1. |
金珍琳，金婷，庄强. 艾曲泊帕治疗原发免疫性血小板减少症患者的回顾性研究. 中国现代医生. 2024(11): 69-72 .
| |
| 2. |
马丽，包萃华. TPO受体激动剂在难治性原发免疫性血小板减少症中的研究进展. 内蒙古医学杂志. 2024(07): 927-930+934 .
| |
| 3. |
李亮，卞建军，苏玉璇，沈磊，傅磊. 海曲泊帕乙醇胺片联合环孢素A治疗难治性免疫性血小板减少症的临床疗效及安全性. 现代生物医学进展. 2024(24): 4695-4699 .
| |
| 4. |
袁文志. 艾曲泊帕联合环孢素治疗原发性血小板减少症的临床疗效分析. 中外医疗. 2024(34): 82-85 .
| |
| 5. |
梅婷，孙小力，齐淑静，魏广祎. 自拟益气健脾解毒化瘀方联合艾曲泊帕治疗恶性肿瘤化疗相关性血小板减少症的临床效果. 临床误诊误治. 2023(06): 138-142 .
| |
| 6. |
胡星月，赵彤，张思源，乐丽霞，宋朋飞，李洁. 联合用药治疗成人原发免疫性血小板减少症. 中国医药科学. 2023(14): 45-48+85 .
| |
| 7. |
张潇，回广飞，任天舒，许子华，周春娟，王艳帅，赵俭. 异基因造血干细胞移植患者环孢素血药浓度及影响因素分析. 临床军医杂志. 2022(09): 926-929 .
| |
| 8. |
周林，禹红，万敏，刘毓玲，段波，王进军. 芪黄汤对免疫性血小板减少症小鼠作用机制研究. 临床军医杂志. 2022(09): 975-977 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: